Nature Search

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

The practical rules for the early non-invasive diagnosis of cirrhosis in NAFLD are not well defined. Here, the authors develop and validate two diagnostic tools: a stepwise stratification algorithm including a cirrhosis group, and a risk prediction chart providing a personalized assessment of the individual probability of cirrhosis.

Jérôme Boursier
Marine Roux
Philip N. Newsome
ResearchOpen Access26 Aug 2023
Nature Communications

Volume: 14, P: 1-11
Sexual quality of life is impaired in patients with chronic hepatitis C

J Vergniol
S Duc
V de Lédinghen
Research11 Feb 2016
International Journal of Impotence Research

Volume: 28, P: 68-73
Cystic fibrosis and noninvasive liver fibrosis assessment methods in children

Raphael Enaud
Eric Frison
Thierry Lamireau
Research17 Mar 2021
Pediatric Research

Volume: 91, P: 223-229
Advancing the global public health agenda for NAFLD: a consensus statement

Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease with a substantial burden worldwide. In this Consensus Statement, a global multidisciplinary group of experts develop consensus statements and recommendations addressing a broad range of topics on NAFLD to raise awareness and spur action.

Jeffrey V. Lazarus
Henry E. Mark
Ming-Hua Zheng
Reviews27 Oct 2021
Nature Reviews Gastroenterology & Hepatology

Volume: 19, P: 60-78
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

The combination of increasing disease prevalence and the prospect of approved pharmacological treatments has made the development of noninvasive biomarkers for NAFLD and NASH a research priority. In this Review, the authors comprehensively summarize the features of current and potential biochemical, imaging and genetic biomarkers.

Vincent Wai-Sun Wong
Leon A. Adams
Silvia Sookoian
Reviews29 May 2018
Nature Reviews Gastroenterology & Hepatology

Volume: 15, P: 461-478
Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study

M. Lahouati
C. Cazanave
Gaétane Wirth
ResearchOpen Access16 Sept 2023
Scientific Reports

Volume: 13, P: 1-8
Quantification of portal–bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C

Jérémy Sandrini
Jérôme Boursier
Marie-Christine Rousselet
Research03 Jan 2014
Modern Pathology

Volume: 27, P: 1035-1045
Immunohistochemical Detection of HCV in Cirrhosis, Dysplastic Nodules, and Hepatocellular Carcinomas with Parallel-Tissue Quantitative RT-PCR

Anne Rullier
Pascale Trimoulet
Brigitte Le Bail
Research01 May 2001
Modern Pathology

Volume: 14, P: 496-505

Search

Filter By:

Search

Quick links